ABSTRACT The kinetic properties and the control mechanism of fructose-6-phosphate 2-kinase (ATP: D-fructose-6-phosphate 2-phosphotransferase) were investigated. The molecular weight of the enzyme is -100,000 as determined by gel filtration. The plot of initial velocity versus ATP concentration is hyperbolic with a K. of 1.2 mM. However, the plot of enzyme activity as a function of fructose 6-phosphate is sigmoidal. The apparent K0.5 for fructose 6-phosphate is 20 ,IM. Fructose-6-phosphate 2-kinase is inactivated by -the catalytic subunit of cyclic AMP-dependent protein kinase, and the inactivation is closely correlated with phosphorylation. The enzyme is also inactivated by phosphorylase kinase in the presence of Ca2" and calmodulin. The phosphorylated fructose-6-phosphate 2-kinase, which is inactive, is activated by phosphorylase phosphatase and alkaline phosphatase. The possible physiological significance of these observations in the coordinated control of glycogen metabolism and glycolysis is discussed. Phosphofructokinase is a key regulatory enzyme of glycolysis whose activity is controlled by various metabolites (1). Our investigation into the biochemical mechanism ofhormonal control of phosphofructokinase in liver has revealed the existence of an "activation factor" that effectively releases ATP inhibition ofthe enzyme (2, 3) . This factor appears to play an important role in the control of phosphofructokinase in hepatocytes: (i) its concentration is altered rapidly by glucagon or glucose (4), (ii) the enzyme has an extremely high affinity for the factor (5), and (iii) this affinity varies depending on the phosphorylation state ofphosphofructokinase (6). Moreover, the discovery ofthe activation factor has provided a plausible explanation for a puzzling phenomenon. Glycolysis in-the liver proceeds at a rate that requires at least 30% of the total hepatic phosphofructokinase to be active (2). However, a calculation based on the in vitro determination of hepatic phosphofructokinase activity in the presence of in vivo concentrations of ATP, fructose 6-phosphate, and other known effectors shows that the enzyme would be totally inactive. It now appears that the activation factor may relieve this inhibition ofphosphofructokinase under in vivo conditions and thus allow hepatic glycolysis to proceed. A similar factor has also been isolated by van Schaftingen and Hers (7), who tentatively characterized it as fructose 2,6-bisphosphate (8). Subsequently, its structure was determined as P-D-fructose-2,6-bisphosphate (9, 10).
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We have recently found that the enzyme fructose-6-phosphate 2-kinase (ATP:D-fructose-6-phosphate 2-phosphotransferase) catalyzes the synthesis of fructose 2,6-bisphosphate in the presence of fructose 6-phosphate and ATP (11) (Eq. 1).
Fructose 6-phosphate + ATP -3 Fructose 2,6-bisphosphate + ADP. [1] We have shown that the administration of extremely low concentrations of glucagon (0.1 fM) or high concentrations of epinephrine (10 ,uM) to hepatocytes results in inactivation of fructose-6-phosphate 2-kinase and concomitant decrease in the fructose 2,6-bisphosphate level (12) . These results, as well as more recent data using Ca2+ and the Ca2+ ionophore A23187 (unpublished results) suggest that the regulation of fructose-6-phosphate 2-kinase is complex and may involve both cyclic AMP (cAMP)-dependent and Ca2+-mediated mechanisms (12) . In this communication, we present evidence that fructose-6-phosphate 2-kinase is inactivated by phosphorylation and activated by dephosphorylation in vitro.
MATERIALS AND METHODS
Fructose 2,6-bisphosphate was prepared as described (10) . [y-32P]ATP (3000 Ci/mmol; 1 Ci = 3.7 x 10'°becquerels) was from Amersham. A catalytic subunit of porcine cAMP-dependent protein kinase (type II; specific activity, 20 ,umol Of 32p incorporated into histone-min -mg1) was a gift from James T. Stull (University of Texas Health Science Center at Dallas). Phosphorylase phosphatase was provided by D. L. Brautigan and E. H. Fischer (University of Washington, Seattle, WA). Rabbit muscle phosphofructokinase was purified as described (13) . Rabbit skeletal muscle phosphorylase kinase was purified according to the method of Cohen (14) through the Sepharose 4B step. Phosphorylase kinase/protein kinase inhibitor was from Sigma. All other enzymes were products of Boehringer Mannheim. A high-pressure liquid chromatography (HPLC) exclusion gel column, Micro Pak TSK 3000 SW, was from Varian.
Assay for Fructose 2,6-bisphosphate. Fructose 2,6-bisphosphate was assayed by using rabbit muscle phosphofructokinase as described (5) .
Assay for Fructose-6-phosphate 2-kinase. Fructose-6-phosphate 2-kinase was assayed in 0.05 M Tris-HCl, pH 7.4/5 mM ATP/0.2 mM fructose 6-phosphate/7.5 mM MgCl2 (final vol, 0.1 ml). The mixture was incubated at 30°C and, at various time intervals, aliquots (10 ,ul) The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
Al of 0.1 M NaOH to stop the reaction. Aliquots of the alkalitreated reaction mixture were then assayed for fructose 2,6-bisphosphate as described (5) . One unit ofactivity is defined as the amount of enzyme that catalyzes the formation of 1 Amol of Dfructose 2,6-bisphosphate per min under these conditions (11) .
Preparation of Fructose-6-phosphate 2-kdnase. Fructose-6-phosphate 2-kinase was purified as described (11) with the following modification. Fed rats (usually three) were killed with injection of =0.3 ml of Nembutal. The livers were quickly removed and homogenized in a Polytron homogenizer in 3 vol of 50 mM Tris phosphate, pH 8/5 mM ethylene glycol bis(,3-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA) at 40C. The subsequent centrifugation, polyethylene glycol precipitation, and DEAE-cellulose chromatography were carried out as described (5) . The enzyme was eluted from the DEAE-cellulose column with 50 mM Na phosphate/O.2 mM ATP/0.20 M NaCl. The enzyme solution was concentrated to 2 ml with an Amicon concentrator using a PM30 membrane, and the concentrated enzyme was placed on a Sephadex G-200 column (1.5 cm X 65 cm) that had been equilibrated with 50 mM Tris phosphate, pH
NaCl. The enzyme was eluted with the same solution. The fractions containing the enzyme (usually 1.5 times the void volume) were pooled, concentrated with an Amicon concentrator as above, and stored at -75°C. The specific activity ofthe enzyme was =20 milliunits/mg.
HPLC. High speed gel filtration of fructose-6-phosphate 2-kinase was carried out with a TSK 3000 SW column using a HPLC instrument model 204 (Waters). The column was equilibrated with 50 mM Na phosphate, pH 7.4/0.1 mM ATP/0.2 mM dithiothreitol. The enzyme was eluted with the same buffer at 25°C at a flow rate of 1 ml/min and 0.5-ml aliquots were collected.
RESULTS
Properties ofFructose-6-phosphate 2-kinase. The Mr offructose-6-phosphate 2-kinase, as determined by gel filtration on a Sephadex G-200 column, is =100,000 ( Fig. 1 ). When the phosphorylated enzyme was isubjected to NaDodSO4/acrylamide gel electrophoresis as discussed below, the dissociated enzyme showed a Mr of 55,000. These results suggest that the native enzyme consists of two subunits. phate 2-kinase was incubated with MgATP and the catalytic subunit of cAMP-dependent protein kinase, the enzyme was rapidly inactivated (Fig. 3) . To avoid dilution of [32P]ATP, a limited amount (2 ,uM) ofATP was used in this experiment. The enzyme was, however, inactivated completely when additional ATP (8 mM) was added to the reaction mixture after 35 min.
Tihe rate of 32p incorporation into the enzyme was determined in the same reaction mixture by removing aliquots at given time intervals, and 32p in the trichloroacetic acid-precipitated protein was measured. As shown, the rates of 32p incorporation and the inactivation were similar. The 32p in the trichloroacetic acidprecipitated protein was completely hydrolyzed in 0.3 M NaOH when incubated for 20 hr at 370C, suggesting that the phosphate is linked to a serine (or threonine) residue in the protein.
To ascertain that 32p is incorporated into fructose-6-phosphate 2-kinase, 32P-labeled and inactivated enzymes were subjected to HPLC molecular sieve filtration using a TSK 3000 SW column (Fig. 4) . The elution patterns for fructose-6-phosphate 2-kinase and ATP are shown in Fig. 4A . The enzyme eluted at 12-14 min, and ATP eluted after 17 min. When the 32P-labeled fructose-6-phosphate 2-kinase was chromatographed on the same column (Fig. 4B) , the major 32P-containing protein peak corresponded to the enzyme. The residual activity (5% of the original) of the enzyme is also seen in the same fractions. Furthermore, NaDodSO4gel electrophoresis ofthe 32P-containing enzyme peak fraction showed a single radioactive band, suggesting that only fructose-6-phosphate 2-kinase is phosphorylated (data not shown). The 32P-labeled enzyme band (relative mobility, 0.52 where the mobility of bromophenol blue is 1.0) corresponds to a Mr of 55,000 as compared with marker proteins such as citrate synthase and phosphofructokinase. Inactivation of fructose-6-phosphate 2-kinase and reactivation by phosphatases was further investigated, and the results are summarized in Table 1 . Inactivated fructose-6-phosphate 2-kinase can be reactivated by alkaline phosphatase (Escherichia coli) and phosphorylase phosphatase. As shown in Table  1 , fructose-6-phosphate 2-kinase, which had been inactivated 95% after phosphorylation with cAMP-dependent protein kinase, regains 68% of the original activity after incubation with alkaline phosphatase. Similarly, the inactivated-phosphorylated fructose-6-phosphate 2-kinase is reactivated by a highly purified muscle phosphorylase phosphatase that has been activated by 328 Biochemistry: Furuya et al. Table 2 (experiment A), fructose,6-phosphate 2-kinase is also inactivated by purified phosphorylase kinase from skeletal muscle in the presence of Ca2+ and calmodulin. The phosphorylase kinase preparations were free of protein kinase; therefore, this inactivation was not due to possible contamination with protein kinase. Moreover, the inactivation by phosphorylase kinase is dependent on both Ca2' and calmodulin. In the absence ofCa2+ but the presence of EGTA, inactivation offructose-6-phosphate 2-kinase does not occur. The requirement for calmodulin is also demonstrated.
The inactivated fructose-6-phosphate 2-kinase after phosphorylation by phosphorylase kinase treatment is also fully reactivated by alkaline phosphatase ( Table 2 , experiment B).
DISCUSSION
Administration of glucagon and cAMP to hepatocytes results in a rapid decrease in the level of fructose 2,6-bisphosphate (4), resulting from inactivation of fructose-6-phosphate 2-kinase (12) . Furthermore, epinephrine also decreases the level offructose 2,6-bisphosphate (12) . In additional experiments using Ca2+-depleted hepatocytes and ionophore A23187 to facilitate sible mechanisms for cAMP-dependent and -independent inactivation of fructose-6-phosphate 2-kinase. In addition to the control of fructose-6-phosphate 2-kinase by phosphorylation and dephosphorylation, this enzyme shows sigmoidal saturation kinetics with respect to fructose 6-phosphate (Fig. 1B) , suggesting that the enzyme activity may also be regulated by the fructose 6-phosphate concentration. This is reminiscent of phosphofructokinase but, unlike phosphofructokinase, this enzyme is not inhibited by ATP.
One of the primary functions of liver is to maintain blood glucose level. When glycogen breakdown is stimulated by fasting or hormonal stimulation, glucose utilization by liver must be slowed to put out more glucose. As shown in Scheme II, when glycogenolysis is stimulated after glucagon release, the concentrations of both glucose 6-phosphate (Glu-6-P) and fructose 6-phosphate (Fru-6-P) increase severalfold. This increase in fructose 6-phosphate, a positive effector, can cause activation of phosphofructokinase and thus activate glycolysis. However, glycolysis must be stopped to convert glucose 6-phosphate into glucose (heavy arrow). Therefore, activation of glycogen breakdown (heavy arrows) and inhibition of glycolysis must be coordinately controlled. Ifour in vitro observations can be applied to liver, the coordinated control of these pathways can be accomplished as follows. As the cAMP or Ca2' level increases, glycogenolysis is stimulated by the well-known cascade mechanism (18) involving activation of cAMP-dependent protein kinase (Pr kinase), phosphorylase kinase (Ph kinasea), and phosphorylase. At the same time, these protein kinases will inactivate fructose-6-phosphate 2-kinase (Fru-6-P 2-kinasea), Glucose Lactate -Fru-6-P -Glu-6-P < Glu-1-P < Glycogen
Fru-2,6-P2 resulting in a decreased level offructose 2,6-bisphosphate, and thus inhibition of phosphofructokinase as well as glycolysis occurs. Similarly, the same inhibitory mechanism of fructose-6-phosphate 2-kinase could occur when gluconeogenesis is stimulated in liver.
As the concentration of blood glucose increases, glycogen synthesis and glycolysis may be stimulated by the reversal of the above reactions. The inactive phosphorylated fructose-6-phosphate 2-kinase (Fru-6-P 2-kinaseb) can be activated by the dephosphorylation reaction catalyzed by a phosphatase such as phosphorylase phosphatase, which results in an increased concentration of fructose 2,6-bisphosphate, and thus activation of phosphofructokinase (PFK) (--*) and glycolysis. It is especially interesting that phosphorylase phosphatase, which converts phosphorylase a to phosphorylase b, also acts on the phosphorylated fructose-6-phosphate 2-kinase, suggesting that the control ofglycogen synthesis is also coordinated with glycolysis. Thus, the activation and the inactivation of fructose-6-phosphate 2-kinase by phosphorylation and dephosphorylation, respectively, may play a key role in homeostasis ofglucose in liver.
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